Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nektar Therapeutics
Free Cash Flow Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Free Cash Flow
-$175.4m
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
-14%
Johnson & Johnson
NYSE:JNJ
Free Cash Flow
$20.7B
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Free Cash Flow
$13.8B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Free Cash Flow
$4.8B
CAGR 3-Years
-45%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Merck & Co Inc
NYSE:MRK
Free Cash Flow
$14.8B
CAGR 3-Years
21%
CAGR 5-Years
11%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Free Cash Flow
-$2.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nektar Therapeutics's Free Cash Flow?
Free Cash Flow
-175.4m USD

Based on the financial report for Jun 30, 2024, Nektar Therapeutics's Free Cash Flow amounts to -175.4m USD.

What is Nektar Therapeutics's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-14%

Over the last year, the Free Cash Flow growth was 28%. The average annual Free Cash Flow growth rates for Nektar Therapeutics have been 18% over the past three years , 13% over the past five years , and -14% over the past ten years .

Back to Top